IOVA 8-K 2026-10-29

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) 8-K dated 2026-10-29 — accession 0001104659-26-120261.

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) is a biotechnology company listed on US.

IOVANCE BIOTHERAPEUTICS, INC. filed a 8-K on 2026-10-29. Accession 0001104659-26-120261.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. Revenue was up 60.6% from 2024-12-31 to 2025-12-31. IOVA currently screens at market cap $1.89B.

Not investment advice. The IOVA SEC hub lists recent forms. The stock page is the research view.